MI Bioresearch Joins the Covance Family

Now, in addition to accessing hundreds of pharmacology tumor models and preclinical cell line assays, you can also partner with us for clinical trials and post-market oncology studies to support your preclinical and clinical oncology pipeline.

Your next cancer breakthrough could be one study away.

One Focus. One Purpose. Oncology Research.

Pharmacology Expertise | Leading Technology | Data-driven Insight

Solutions To Advance Your Preclinical Oncology Research

Preclinical oncology provides in vitro and in vivo pharmacology services, in vivo imaging technologies and focal radiation capabilities. Our team helps you to explore the effects of drugs and biologics, using both human and syngeneic tumor models, and provides you with decision-driving data to advance your drug candidate toward the next cancer research breakthrough.

When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools, and experience to move life-changing drug candidates through non-GLP, preclinical development and oncology clinical trials quickly and efficiently.

Preclinical Oncology Services and Solutions

Immuno-Oncology

Immuno-Oncology

We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research.

In Vivo Pharmacology

In Vivo Pharmacology

Our scientists will work collaboratively with you to create an approach to help you thoroughly evaluate your drug candidates; then provide you with high quality data to make key decisions about your agent or program.

In Vitro Services

In Vitro Services

We offer a full suite of molecular and cellular biology assays to address the invaluable need for analysis of target and drug activity before, during, and after an in vivo experiment.

Imaging

Imaging

We have harnessed the power of in vivo imaging for over a decade, offering services on the widest breadth of state-of-the-art instrumentation available.